Do you want to make wiser business decisions? Give your critical thinking skills a reboot. In Episode 20 of his “From Lab to Patient, Garage to Market” podcast, host Philip Crowley welcomes Christopher Frank, chief executive officer at the global marketing research and consulting firm PSB Insights, for an engaging discussion on how critical thinking in data analysis can lead to more innovative entrepreneurship. In one highlight, Frank explores what he calls the “Context Triangle,” an approach that considers data from three distinct views: 1. Absolute Value: Is the number significant enough to matter? 2. The Trend Over Time: Has the number changed in a meaningful way? 3. Benchmark Comparison: How does it compare to industry or competitor norms? “You should never look at data in a vacuum,” Frank explains. “Data should always be in context. If you do that, you will start to move down a path of being a critical thinker.” Frank also cautions listeners to avoid the “analysis paralysis” that often comes from relying too heavily on being either a data-driven or an intuitive decision-maker. Instead, he advises that a more intersectional approach to the two methods will lead to greater and more sustainable success. In addition to his role with PSB Insights, Christopher Frank is co- author of the acclaimed books “Decisions Over Decimals: Striking the Balance between Intuition and Information” and “Drinking from the Fire Hose: Making Smarter Decisions Without Drowning in Information.” His thought leadership, expertise and industry impact have been spotlighted by Fortune, Forbes, Harvard Business Review and other prominent media outlets. Crowley encourages his clients and newsletter readers to experience this podcast episode and Frank’s invaluable insights for themselves. As he says at the beginning of this episode, “Chris is a master at turning data into actionable strategies that can lead to success and drive a business. I think that is particularly relevant for our digital companies and entrepreneurs in our audience.” Hosted by Crowley Law LLC Founder and Managing Partner Philip Crowley, the “From Lab to Patient, Garage to Market” podcast explores the critical issues and concerns impacting the biotech, life sciences and startup markets by offering fresh perspectives from industry leaders and experts. It is available on YouTube, LinkedIn, Facebook, Apple Podcasts, Spotify, all the major podcast channels and at CrowleyLawLLC.com . From Lab to Patient, Garage to Market Inside ‘The Context Triangle’ With Christopher Frank
... continued from Cover
EverTree Bio’s cutting-edge work is directed by its founder and CEO, Dr. Sarah Kishinevsky, Ph.D. While working to complete her Ph.D in neuroscience, she founded and led BioVenture eLab, a first-of-its-kind entrepreneurship department at Weill Cornell Medicine in New York. Her dissertation — a collaborative research project between the Lorenz Studer and Gabriela Chiosis laboratories — resulted in the publication of (as stated on her LinkedIn page) “druggable targets for Parkinson’s disease by combining pluripotent stem cell and medicinal chemistry advancements in [her] co-sponsors’ laboratories.” Additionally, she spent several years as an independent strategy consultant, guiding idea-stage biotech inventors through commercialization and business plan development. Her ingenuity and commitment to innovation led her to initiate EverTree Bio roughly 18 months ago. I first met her while I served as a mentor at BioVenture eLab, and I have followed her subsequent career with great interest. Not surprisingly, Dr. Kishinevsky expressed her excitement over EverTree Bio’s groundbreaking work in a recent interview for this newsletter. “I love our team and knowing that we all have the same end goal of helping patients. It’s not just an academic exercise to find the best widget; we’re doing things that are very meaningful to us.”
Additionally, she shared some very kind words about her company’s work with Crowley Law LLC.
“Phil has very tailored advice for everyone here. He’s very to-the- point and considers practical solutions in response to what he hears. It’s easy to feel his passion for emerging technologies and his genuine desire to help. I thought of him immediately when we started our company, and I have been very happy with his work with us.” I’m delighted that our firm has helped EverTree Bio’s mission, and I’m excited to see how its work in treating Charcot-Marie- Tooth and other neurological disorders will progress. Dr. Kishinevsky and her team demonstrate the advancements possible in seeking new solutions to longstanding medical challenges and serve as a reminder of what makes life sciences and technology so fascinating. I wish them — and all my colleagues and clients — well in their work to broaden scientific knowledge and facilitate new directions in human healing.
Note: The foregoing may constitute attorney advertising under applicable bar rules.
–Philip Crowley
908-460-5529 — 3
Made with FlippingBook Ebook Creator